A phase II clinical study of adebrelimab and bevacizumab combined with cisplatin/ carboplatin in triple-negative breast cancer patients with brain metastases

Category Primary study
Conference2025 ASCO Annual Meeting I
Year 2025
This article has no abstract
Epistemonikos ID: 555f1a4c2b05f77ab09f3f213c4e514465d88650
First added on: Sep 03, 2025